TriStrata Technology, Inc. (TTI), a Princeton, NJ-based subsidiary of NeoStrata, won a patent infringement suit in November 2003 against Valeant Pharmaceuticals International, formerly ICN Pharmaceuticals. A U.S. District Court jury in Wilmington, DE, found seven claims for the two patents were willfully infringed. On April 12, the court rejected Valeant’s motion to overturn and issued a permanent injunction prohibiting Valeant from the manufacture, sale and marketing of products covered by the...